Donald W DeGolyer
CIK 1583098 · Chief Operating Officer,Pharma · last filed 2026-05-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$948.3K
Companies
3
Total Filings
23
Lifetime Open-Market Net
-$658.2K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EBS | Director | 129,721 | $7.31 | $948.3K | -$658.2K | 7 | 2026-05-04 |
| TYME TECHNOLOGIES, INC. (TYME) Delisted | Director | — | $0.31 | — | $0 | 7 | 2022-09-16 |
| Endo International plc (ENDP) Delisted | Chief Operating Officer,Pharma | 6,547 | $0.29 | $1.9K | $0 | 5 | 2015-03-02 |
Recent Filings · Page 2 of 3
23 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-10-05 | EBS | Grant (A) | +118,670 | $0 | EDGAR |
| 2022-09-16 | TYME TECHNOLOGIES, INC. (TYME) Delisted | Disp (D) | — | $0 | EDGAR |
| 2022-08-29 | TYME TECHNOLOGIES, INC. (TYME) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-08-26 | TYME TECHNOLOGIES, INC. (TYME) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-08-24 | TYME TECHNOLOGIES, INC. (TYME) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-08-27 | TYME TECHNOLOGIES, INC. (TYME) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-08-28 | TYME TECHNOLOGIES, INC. (TYME) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-05-29 | TYME TECHNOLOGIES, INC. (TYME) Delisted | Grant (A) | — | $0 | EDGAR |
| 2015-03-02 | Endo International plc (ENDP) Delisted | Tax (F) | −477 | -$40.6K | EDGAR |
| 2014-08-05 | Endo International plc (ENDP) Delisted | Tax (F) | −4,459 | -$303.7K | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.